课题基金 / 基金详情

HIGH DOSE METHOTREXATE WITH LEUCOVORIN RESCUE IN RHEUMATOID ARTHRITIS

HIGH DOSE METHOTREXATE WITH LEUCOVORIN RESCUE IN RHEUMATOID ARTHRITIS
高剂量甲氨蝶呤联合亚叶酸拯救类风湿性关节炎
批准号:
3822946
负责人:
J H KLIPPEL
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

J H KLIPPEL的其他基金

相似基金

相关文献

中文摘要
翻译
5例重症难治性类风湿患者 大剂量甲氨蝶呤静脉注射治疗关节炎 亚叶酸钙500 mg/m2,亚叶酸钙50 mg/m2。四道菜 化疗间隔超过2个月。在…的末尾 最后一个疗程,关节有50%或更多的改善 所有患者的肿胀和疼痛指数以及晨僵。 治疗后临床反应持续6-14周。高 剂量甲氨蝶呤-亚叶酸钙与显著的 外周血亮氨酸2、亮氨酸3细胞DR抗原表达降低 Leu-4淋巴细胞。
英文摘要
Five patients with severe, treatment refractory rheumatoid arthritis were treated with high dose intravenous methotrexate (500mg/m2) followed by leucovorin (50 mg/m2). Four courses of chemotherapy were given over a 2 month interval. At the end of the final course, there are a 50% or greater improvement in joint swelling and pain indices and morning stiffness in all patients. Clinical responses persisted for 6 to 14 weeks post therapy. High dose methotrexate-leucovorin was associated with a significant reduction in DR antigen expression on peripheral Leu 2, Leu 3 and Leu 4 lymphocytes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL AND THERAPEUTIC STUDIES OF THE RHEUMATIC DISEASES
CLINICAL AND THERAPEUTIC STUDIES OF THE RHEUMATIC DISEASES
CLINICAL AND THERAPEUTIC STUDIES OF THE RHEUMATIC DISEASES
CLINICAL AND THERAPEUTIC STUDIES OF THE RHEUMATIC DISEASES
海外基金